文献速递认知障碍与痴呆

脑脊液神经丝轻链蛋白与无认知障碍人群轻度认知障碍风险的相关性

Association of Cerebrospinal Fluid Neurofilament Light Protein With Risk of Mild Cognitive Impairment Among Individuals Without Cognitive Impairment.
PubMed 文献 · JAMA Neurol · 2019-01-01

基于Mayo Clinic老化研究前瞻性人群队列,648名无认知障碍参与者随访中位3.8年,96人(14.8%)发生轻度认知障碍;脑脊液神经丝轻链蛋白最高四分位组较最低四分位组轻度认知障碍风险增加3.1倍(HR 3.13,95%CI 1.36-7.18),而总tau、磷酸化tau和神经颗粒素均与风险无关,且该关联独立于脑淀粉样变。

要点

  • 脑脊液神经丝轻链蛋白最高四分位组较最低四分位组轻度认知障碍风险增加3.1倍(HR 3.13,95%CI 1.36-7.18)。
  • 脑脊液总tau、磷酸化tau和神经颗粒素水平均与轻度认知障碍风险无显著关联。
  • 脑脊液Aβ42与神经丝轻链蛋白对轻度认知障碍风险无交互作用。

核心结论

  • 在社区人群中,脑脊液神经丝轻链蛋白水平升高而非总tau、磷酸化tau或神经颗粒素是轻度认知障碍的危险因素,且独立于脑淀粉样变。

研究设计与样本

  • 前瞻性人群队列研究,纳入2004年1月至2015年12月Mayo Clinic老化研究中648名无认知障碍且有脑脊液数据和至少1次随访的参与者,随访中位3.8年(四分位距2.6-5.4年),基线中位年龄72.3岁(范围50.7-95.3岁),男性366人(56.5%)。

主要发现

  • 96人(14.8%)发生轻度认知障碍。
  • 多变量模型中,脑脊液神经丝轻链蛋白最高四分位组较最低四分位组轻度认知障碍风险增加3.1倍(HR 3.13,95%CI 1.36-7.18)。
  • 脑脊液总tau、磷酸化tau和神经颗粒素均与轻度认知障碍风险无显著关联。
  • 脑脊液Aβ42与神经丝轻链蛋白对轻度认知障碍风险无交互作用。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Accumulating data suggest that elevated cerebrospinal fluid (CSF) neurofilament light (NfL) and neurogranin (Ng) levels are associated with cognitive decline and may be useful markers of neurodegeneration. However, to our knowledge, previous studies have not assessed these CSF markers in the community, evaluated them with regards to risk of mild cognitive impairment (MCI), or compared their prognostic value with CSF total tau (T-tau) or phosphorylated tau (P-tau). OBJECTIVE: To determine (1) whether CSF NfL and Ng levels were associated with risk of MCI, (2) the effect size of these markers compared with CSF T-tau or P-tau for risk of MCI, and (3) whether CSF amyloid-β (Aβ42) modified these associations. DESIGN, SETTING AND PARTICIPANTS: The analyses included 648 participants without cognitive impairment who were enrolled into the prospective population-based Mayo Clinic Study of Aging between January 2004 and December 2015 with available CSF data and at least 1 follow-up visit. Participants were followed up for a median of 3.8 years (interquartile range, 2.6-5.4 years). The CSF NfL and Ng levels were measured using an in-house sandwich enzyme-linked immunosorbent assay. The CSF Aβ42, T-tau, and P-tau levels were measured with automated electrochemiluminescence immunoassays. Cox proportional hazards models, with age as the timescale, were used to assess the association between CSF NfL, Ng, Aβ42, T-tau, or P-tau with risk of MCI after adjusting for sex, education, apolipoprotein E genotype, and the Charlson comorbidity index. To examine CSF Aβ42 as an effect modifier, it was categorized into tertiles; the bottom tertile was defined as having elevated brain amyloid. MAIN OUTCOMES AND MEASURES: Risk of MCI. RESULTS: At baseline, the median age of the 648 participants without cognitive impairment was 72.3 years (range, 50.7-95.3 years) and 366 (56.5%) were men; 96 (14.8%) developed incident MCI. Compared with the bottom quartile, the top quartile of CSF NfL was associated with a 3.1-fold increased risk of MCI (hazard ratio, 3.13; 95% CI, 1.36-7.18) in multivariate models. Neither CSF T-tau, P-tau, nor Ng was associated with risk of MCI. There was no interaction between Aβ42 and CSF NfL for risk of MCI. CONCLUSIONS AND RELEVANCE: Elevated CSF NfL levels but not CSF T-tau, P-tau or Ng are a risk factor for MCI in a community population and are independent of brain amyloid.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Kern S, Syrjanen JA, Blennow K, et al. Association of Cerebrospinal Fluid Neurofilament Light Protein With Risk of Mild Cognitive Impairment Among Individuals Without Cognitive Impairment. JAMA Neurol. 2019. PMID: 30419087. doi:10.1001/jamaneurol.2018.3459

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。